Pharmaceutical
- All
- News
- Videos
- Photos
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
Gita Gopinath Slams Trump's Tariffs: "Negative Scorecard" For US Economy
Gita Gopinath evaluated the impact of US President Donald Trump's tariffs and concluded that they have yielded little to no benefits for the US economy.
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
India Offers Expertise To Central American Nations In Digital, Health And Agricultural Sectors
External Affairs Minister S Jaishankar has offered India's expertise to Central American countries in the fields of digital payment system, information technology, pharmaceuticals, and agriculture to tackle shared problems.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
Gita Gopinath Slams Trump's Tariffs: "Negative Scorecard" For US Economy
Gita Gopinath evaluated the impact of US President Donald Trump's tariffs and concluded that they have yielded little to no benefits for the US economy.
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
India Offers Expertise To Central American Nations In Digital, Health And Agricultural Sectors
External Affairs Minister S Jaishankar has offered India's expertise to Central American countries in the fields of digital payment system, information technology, pharmaceuticals, and agriculture to tackle shared problems.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
